Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 40Neoplasm Metastasis 7Neoplasms 6Breast Neoplasms, Male 6Unspecified Adult Solid Tumor, Protocol Specific 3Ovarian Neoplasms 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Solid Tumors 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumors 2Waldenstrom Macroglobulinemia 1Thyroid Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Oligodendroglioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

pazopanib 3Erlotinib Hydrochloride 3Cetuximab 3Vorinostat 2Oxaliplatin 2Bevacizumab 2Azacitidine 2satraplatin 1ixazomib 1X-Rays 1Valproic Acid 1Trastuzumab 1Sorafenib 1Platinum 1Pemetrexed 1Magnetic Resonance Spectroscopy 1Leucovorin 1Lenalidomide 1Lapatinib 1LY 2275796 1Injections, Subcutaneous 1Fluorouracil 1Everolimus 1Curcumin 1Crizotinib 1Capecitabine 1Albumin-Bound Paclitaxel 1AH 111585 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Cancers × Lapatinib × Clear all
NCT01454804 2016-04-13

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Completed
43 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡